Skip to main content
Back to SV Angel

SV Angel's Biotechnology Portfolio

Browse 17 Biotechnology companies funded by SV Angel. See funding amounts, founder contacts, and investment details.

Biotechnology Companies
17
Total Funding in Biotechnology
$1.1B

Biotechnology Portfolio Companies (17)

Export
BiotechnologyGeneticsPharmaceutical

Amber Bio is a biotechnology company pioneering new gene editing modalities using multi-kilobase edits.

San Francisco, United States
August 2023
$26.0M
Seed

Founder Contacts

30,000+ verified contacts

AppsBiotechnologyElectronic Health Record (EHR)GeneticsHealth CarePersonal Health

Color is a healthcare delivery platform that offers cancer prevention, screening programs, and healthcare services for people.

South San Francisco, United States
August 2022
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalPharmaceuticalSoftware

Phil, Inc. offers a tech platform that simplifies prescription delivery, insurance processing, and patient access for pharma brands.

Scottsdale, United States
July 2025
$60.0M
Debt Financing

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyClinical TrialsHealth CareMedicalPharmaceutical

Formation Bio is a drug development company that strives to provide treatments to patients faster by reimagining clinical trials.

New York, United States
June 2024
$372.0M
Series D

Founder Contacts

30,000+ verified contacts

BiotechnologyGeneticsHealth DiagnosticsLife Science

Mammoth Biosciences develops novel CRISPR applications for disease detection, research, agriculture, biodefense, and more.

San Francisco, United States
April 2024
$95.0M
Corporate Round

Founder Contacts

30,000+ verified contacts

BiotechnologyLife Science

Octant Bio is a developer of synthetic technology used to improve health and treat disease.

Los Angeles, United States
April 2022
$80.0M
Series B

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyLife ScienceMarket Research

Phylo provides an integrated workspace with AI-assisted tools to support planning, execution, and review of biological research.

South San Francisco, United States
February 2026
$13.5M
Seed

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BioinformaticsBiotechnologyMachine LearningTherapeutics

Envisagenics reduce the complexity of biomedical data to accelerate the development of innovative therapeutic solutions.

Long Island City, United States
June 2024
$25.0M
Series B

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth CareLife Science

ExcepGen is solving fundamental underlying problems in drug discovery to create a new generation of therapeutics.

San Francisco, United States
August 2023
$4.0M
Seed

Founder Contacts

30,000+ verified contacts

BiotechnologyLife Science

Mantra Bio is the creator of REVEAL, an exosome engineering platform combining computational biology and lab automation.

San Francisco, United States
January 2023
$9.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalMedical DeviceMental HealthTherapeutics

Limbix is a prescription digital therapeutics platform that provides mental health treatment for young people.

Palo Alto, United States
December 2021
$15.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyClinical TrialsCloud ComputingElectronic Health Record (EHR)Health CareHealth DiagnosticsHospitalPersonal Health

Flatiron Health is a healthcare technology company that aims to improve lives by learning from the experience of every cancer patient.

New York, United States
December 2021
$11.9M
Series D

Founder Contacts

30,000+ verified contacts

BiotechnologyCloud Data ServicesIndustrial AutomationRobotics

Culture Biosciences provides automated systems for bioprocess development that help optimize biological products and processes.

San Francisco, United States
December 2025
Series C

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyGeneticsLife SciencePharmaceutical

A comprehensive platform and product suite for advanced therapeutics.

Brisbane, United States
January 2022
Series A

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyProduct Research

Rezo Therapeutics identifies targets and therapies by combining distinct, unbiased technologies with artificial intelligence.

South San Francisco, United States
November 2022
$78.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyGeneticsInnovation ManagementSoftware

Industrial-scale genome sequencing

New York, United States
October 2021
$10.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsMedicalMedical Device

Grail is a healthcare company that develops pan-cancer screening tests designed to detect cancers at an early stage.

Menlo Park, United States
October 2025
$325.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

Explore SV Angel's Full Portfolio

View all companies funded by SV Angel across every industry and funding stage.

View Full SV Angel Portfolio